UB Paderborn / Katalog / Suche / in CDI

Non-bacterial thrombotic endocarditis manifested by ventricular fibrillation in a patient with low grade ovarian carcinoma: case report and literature review

European heart journal : case reports, 2021-04, Vol.5 (4), p.ytab120

2021

Link zum Volltext

Verfügbarkeit prüfen

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study

Research and practice in thrombosis and haemostasis, 2021-01, Vol.5 (1), p.223-230

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of combined oral antithrombotic therapy by an antithrombotic stewardship program: A prospective study

British journal of clinical pharmacology, 2022-09, Vol.88 (9), p.4092-4099

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia

The American journal of cardiology, 2005-01, Vol.95 (2), p.264-266

2005

Link zum Volltext

Verfügbarkeit prüfen

The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study

European journal of cardiovascular prevention and rehabilitation, 2003-12, Vol.10 (6), p.451-455

2003

Link zum Volltext

Verfügbarkeit prüfen

Thoracic outlet syndrome (TROTS) registry: A study protocol for the primary upper extremity deep venous thrombosis section

PloS one, 2023-01, Vol.18 (1), p.e0279708-e0279708

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia

Journal of investigative medicine, 2004-04, Vol.52 (3), p.177

2004

Link zum Volltext

Verfügbarkeit prüfen

Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis

The Lancet. Haematology, 2018-11, Vol.5 (11), p.e512-e519

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia

The American journal of cardiology, 2003-03, Vol.91 (5), p.604-606

2003

Link zum Volltext

Verfügbarkeit prüfen

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

Atherosclerosis, 2002-12, Vol.165 (2), p.361-366

2002

Link zum Volltext

Verfügbarkeit prüfen

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy

Journal of the American College of Cardiology, 2003-01, Vol.41 (2), p.275-279

2003

Link zum Volltext

Verfügbarkeit prüfen

The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia

Atherosclerosis, 2004-04, Vol.173 (2), p.261-267

2004

Link zum Volltext

Verfügbarkeit prüfen

Measurement of atherosclerosis progression

The Lancet (British edition), 2001-07, Vol.358 (9278), p.329-329

2001

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic variability in familial hypercholesterolaemia: an update

Current opinion in lipidology, 2002-04, Vol.13 (2), p.165-171

2002

Link zum Volltext

Verfügbarkeit prüfen

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia

Atherosclerosis, 2008-04, Vol.197 (2), p.916-921

2008

Link zum Volltext

Verfügbarkeit prüfen

Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia

Journal of investigative medicine, 2004-04, Vol.52 (3), p.177-184

2004

Link zum Volltext

Verfügbarkeit prüfen

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial

BMJ open, 2014-09, Vol.4 (9), p.e005265-e005265

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety and efficacy of high-dose aforvastatin treatment in patients with familial hypercholesterolemia

The American journal of cardiology, 2005, Vol.95 (2), p.264-266

2005

Link zum Volltext

Verfügbarkeit prüfen

Effect of atorvaseatin (80 mg) and Simvostatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia

The American journal of cardiology, 2003, Vol.91 (5), p.604-606

2003

Link zum Volltext

Verfügbarkeit prüfen

Non-bacterial thrombotic endocarditis manifested by ventricular fibrillation in a patient with low grade ovarian carcinoma: case report and literature review

European heart journal. Case reports, 2021, Vol.5 (4), p.ytab120-ytab120

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia

Journal of investigative medicine, 2004-04, Vol.52 (3), p.177-184

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia

Journal of investigative medicine, 2004-04, Vol.52 (3), p.177-184

2004

Link zum Volltext

Verfügbarkeit prüfen

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study

Clinical drug investigation, 2000, Vol.20 (2), p.67-79

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Non-bacterial thrombotic endocarditis manifested by ventricular fibrillation in a patient with low grade ovarian carcinoma: case report and literature review

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study

Management of combined oral antithrombotic therapy by an antithrombotic stewardship program: A prospective study

Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia

Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial

The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study

Thoracic outlet syndrome (TROTS) registry: A study protocol for the primary upper extremity deep venous thrombosis section

Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study

Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia

Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis

Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy

The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia

Measurement of atherosclerosis progression

Phenotypic variability in familial hypercholesterolaemia: an update

Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia

Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial

Long-term safety and efficacy of high-dose aforvastatin treatment in patients with familial hypercholesterolemia

Effect of atorvaseatin (80 mg) and Simvostatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia

Non-bacterial thrombotic endocarditis manifested by ventricular fibrillation in a patient with low grade ovarian carcinoma: case report and literature review

Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia

Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study

Suchergebnisse filtern